Please login or register first to view this content.
Urological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
RAAS Inhibitor Discontinuation After Hyperkalemia Tied to Adverse Outcomes
FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Empagliflozin May Reduce Stone Risk
Methotrexate Added to Pegloticase for Gout Safe for Kidneys
Empagliflozin Cuts Risk of Kidney Disease Progression, CV Death in CKD Patients
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Budesonide Improves Kidney Parameters in IgA Nephropathy
White Women Have Lower Liver Transplant Rates Compared With White Men
ACS: Livers Have Potential to Function for Greater Than 100 Years
Sotrovimab Is Safe for COVID-19 in Kidney Transplant Recipients
FDA Needs Additional Time to Review Sparsentan, Tofersen Applications
Patients Undergoing IMV With History of Cirrhosis Have Higher Mortality
Vaginal pH Modulator Misses Primary Endpoint in STI Clinical Trial
Cefepime/Enmetazobactam Noninferior for Complicated UTI
September 2022: Notable Drug Approvals
Oxlumo Indication Expanded to Include Patients With Advanced PH1
Apparent Treatment-Resistant Hypertension Common in CKD